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The interoceptive Pavlovian stimulus effects of caffeine
Jennifer E. Murray, Chia Li, Matthew I. Palmatier1, and Rick A. Bevins
Department of Psychology, University of Nebraska-Lincoln, Lincoln, NE, USA
Abstract
The present research sought to test whether caffeine functioned as a Pavlovian cue in two ways—as
a positive drug feature or as a conditional stimulus (CS). As a positive feature (Experiment 1), brief
light presentations were followed by sucrose only on sessions in which caffeine (10 mg/kg) was
administered. On intermixed saline sessions, light presentations were not followed by sucrose. The
light came to control robust goal-tracking (i.e., conditioned responding) only in caffeine sessions.
Thus, caffeine disambiguates when the light was paired with sucrose. Decreasing the dose of caffeine
decreased the conditioned responding evoked by the light (ED50=4.16 mg/kg). Neither nicotine nor
amphetamine substituted for the caffeine feature. As a CS, caffeine (10 or 30 mg/kg, Experiments
2a and 2b, respectively) signaled intermittent access to sucrose—no light presentations. No sucrose
or lights were presented on intermixed saline sessions. The caffeine CS, regardless of training dose,
acquired the ability to evoke only a weak goal-tracking CR. The nature of this dissociation between
caffeine as a drug feature versus a CS is discussed within the context of past research finding a similar
dissociation with amphetamine and chlordiazepoxide, but not with nicotine.
Keywords
adenosine; acetylcholine; classical conditioning; discriminative stimulus; dopamine; drug
discrimination; modulator; negative feature; occasion setter; reward learning
1. Introduction
Caffeine is one of the more commonly consumed psychoactive substances worldwide and is
present in many beverages such as coffee, tea, and soda (Barone and Roberts, 1984) as well as
energy drinks. The positively reinforcing effects of caffeine include enhanced wakefulness,
increased concentration, and stimulated activity (Daly and Fredholm, 1998;Griffiths et al.,
1990;Griffiths and Woodson, 1988). Importantly, the pharmacological effects of caffeine also
include an interoceptive stimulus that human and non-human animals can use to discriminate
between response options. For example, participants took daily capsules that contained either
caffeine or placebo (Griffiths et al., 1990;Oliveto et al., 1992). Based on self-reported drug
effects, the participants were able to identify which capsule they had received on a given day.
The stimulus effects of caffeine have also been studied in a two-lever operant drug
discrimination task with rats. In this task, the pharmacological effects of caffeine indicate that
responding on one lever (e.g., right) will be reinforced; responding on the left lever will have
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no scheduled result. In intermixed vehicle (no caffeine) sessions the response-reinforcer
contingency is switched such that left lever presses are now reinforced and right presses are
under extinction (Holtzman, 1986,1987;Mariathasan and Stolerman, 1992;Modrow et al.,
1981;Mumford and Holtzman, 1991;Powell et al., 1999).
The pharmacological effects of a drug can also serve as an interoceptive stimulus in Pavlovian
(classical) conditioning tasks. As a conditional stimulus (CS), the drug state directly signals
the occurrence (or absence) of a biologically and motivationally relevant event (i.e.,
unconditioned stimulus or US). As a drug feature (i.e., occasion setter), the drug state signals
whether or not a CS (e.g., illumination of a light) will be paired with a US. In an array of
appetitive and aversive conditioning protocols, such drugs as amphetamine, diazepam,
nicotine, ethanol, cocaine, midazolam, morphine, methadone, pentobarbital, and
chlordiazepoxide function as a CS and/or a drug feature (e.g., Alessi et al., 2002;Besheer et
al., 2004;Bormann and Overton, 1996;Greeley et al., 1984;Jaeger and Mucha, 1990;Maes and
Vossen, 1997;Murray and Bevins, in press;Palmatier et al., 2004,2005;Parker et al.,
1994;Revusky et al., 1982;Sokolowska et al., 2002;Troisi and Akins, 2004;Wilkinson et al.,
2006).
To our knowledge, there has not been a published report on whether caffeine can serve as an
interoceptive stimulus in Pavlovian discrimination tasks. Studying the interoceptive stimulus
effects of a drug using an approach informed by Pavlovian conditioning theory and research
will add to our understanding of drug states in several important ways. First, such an approach
prompts a different set of research questions than those prompted by an operant conditioning
approach. Such questions include those concerned about the nature of the conditioned
associations between stimuli, as well as the possibility that the later functional impact is altered
by the type conditioned associations engendered by different Pavlovian drug discrimination
protocols (see Bevins & Palmatier, 2004;Bevins et al., 2006;Palmatier & Bevins, 2007).
Second, recent research with nicotine trained as a CS suggests that the neuropharmacological
process of a nicotine CS might differ from those of a nicotine discriminative stimulus (Murray
& Bevins, in press). If these dissociations hold in future research, then our understanding of
the contribution of the interoceptive (i.e., subjective) stimulus effects of drug states to drug
abuse liability will require a comprehensive approach.
With these issues in mind, the primary goal of the present research was to assess whether
caffeine functioned as a CS and/or a positive drug feature in a Pavlovian appetitive conditioning
task recently developed in our laboratory. Published research demonstrating that drug states
can serve as a CS for sucrose has primarily focused on nicotine. In these studies, rats received
intermixed nicotine and saline sessions. On nicotine sessions, sucrose was intermittently
available; no sucrose was available on saline sessions. Using anticipatory head entries into the
sucrose receptacle as a measure of conditioned responding (i.e., goal-tracking; Boakes,
1977;Farwell and Ayres, 1979), we found an increase in goal-tracking on nicotine compared
to saline sessions (Besheer et al., 2004;Bevins and Palmatier, 2004;Bevins et al., in
press;Murray and Bevins, in press;Wilkinson et al., 2006). For the present research we used
procedures shown to be effective with nicotine (Besheer et al., 2004) to assess whether caffeine
(10 or 30 mg/kg) could function as an appetitive interoceptive CS in this Pavlovian drug
discrimination task.
In studies examining positive drug features, the drug state indicated that presentation of a
discrete CS (e.g., 15-s presentation of a light or white noise) was followed by brief access to
sucrose. On intermixed saline sessions, the same discrete CS was presented but was not
followed by sucrose. In other words, the drug state occasioned when CS presentations were
reinforced. Conditional control of goal-tracking was demonstrated by a differential increase in
dipper entries during CS presentations only in the drug state (Palmatier et al., 2004,
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2005;Palmatier and Bevins, 2007). For the present research, we used these procedures shown
to be effective with nicotine, amphetamine, and chlordiazepoxide to assess whether caffeine
could function as a positive feature for an appetitive CS-US relation. Notably, this training
protocol is similar to the CS training protocol except that in the feature positive experiment
discrete light CSs are presented (see Materials and methods).
In the present research, caffeine readily functioned as a positive drug feature. Accordingly, a
secondary goal of the present study was to describe the caffeine generalization function and
determine the specificity of the discrimination by testing whether nicotine or amphetamine
could substitute for the caffeine feature. That is, the discrimination might not be specific to the
pharmacological properties of caffeine. Rather, differential control of conditioned responding
might reflect a drug versus no drug or a stimulant versus non-stimulant discrimination. The
substitution pattern by nicotine and amphetamine would allow us to evaluate these possibilities.
2. Materials and methods
2.1. Subjects
Male Sprague-Dawley rats (370±7 g at start of study) were obtained from Harlan (Indianapolis,
Indiana, USA). Rats were housed individually in clear 48.3 × 26.7 × 20.3 cm (l × w × h)
polycarbonate tubs lined with aspen shavings in a colony that was temperature and humidity
controlled. All sessions were conducted during the light portion of a 12 h light:dark cycle.
Water was continuously available in the home cage. Food (Harlan Teklad Rodent Diet) access
was restricted such that rats were kept at 85% of free-feeding body weights. Approximately
every 4 weeks this target 85% weight was increased by 2 g. Protocols were approved by the
University of Nebraska-Lincoln Animal Care and Use Committee and followed the ‘Guide for
the Care and Use of Laboratory Animals’ (National Research Council, 1996).
2.2. Apparatus
Seven conditioning chambers (ENV-008CT; Med Associates, Inc., Georgia, VT, USA)
measuring 30.5 × 24.1 × 21 cm (l × w × h) were used throughout the study. Sidewalls were
aluminum; the ceiling, and front and back walls were clear polycarbonate. Chambers were
equipped with two white cue lights (2.54 cm dia; 28 V, 100 mA) mounted on one sidewall,
14.6 cm above the metal rod floor and 3.5 cm from the front and back walls. Illumination of
the lights served as the discrete cue in the positive feature experiment. A recessed receptacle
(5.2 × 5.2 × 3.8 cm; l × w × d) was centered between the lights on the same sidewall. The
bottom of the receptacle was 13 cm below the center of the lights. A dipper arm raised a 0.1-
ml cup of 26% sucrose solution (w/v) into the receptacle. An infrared emitter/detector unit
mounted 1.2 cm into the receptacle and 3 cm from the floor monitored head entries into the
dipper. A second infrared emitter/detector unit positioned 4 cm above the rod floor bisected
the chamber 14.5 cm from the sidewall containing the receptacle and lights. The number of
times this beam was broken provided a measure of general chamber activity during
generalization and substitution testing (see later). Each chamber was enclosed in a light and
sound attenuating cubicle fitted with a fan to provide airflow and mask noise. A personal
computer with Med Associates, Inc. interface and software (Med-PC for Windows, version
IV) controlled stimulus events and recorded dipper entries and chamber activity.
2.3. Drugs
Caffeine anhydrous, (−)-nicotine hydrogen tartrate, and d-amphetamine sulfate were purchased
from Sigma (St. Louis, MO, USA). Drugs were mixed in 0.9% saline solution (w/v). Nicotine
was adjusted to a pH of 7.0±0.2 using a dilute NaOH solution. All solutions in the positive
feature study (Experiment 1) were injected at 1 ml/kg except for 30 mg/kg caffeine which was
injected at 2 ml/kg during generalization testing. In the CS experiments, caffeine was injected
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at 2 ml/kg. Caffeine and amphetamine were injected intraperitoneally (IP) 15 min before
placement into the chamber; nicotine was injected subcutaneously (SC) 5 min before
placement. Nicotine doses are reported in the base form; remaining drug doses are reported in
salt form. Drug doses, routes of administration, and injection-to-placement intervals were
based on past research from our laboratory and others (Besheer et al., 2004;Holtzman,
1986;Mariathasan and Stolerman, 1992;Palmatier et al., 2004,2005).
2.4. Experiment 1: Caffeine as a Positive Feature
2.4.1. Acquisition—Rats (n=6) that had previously been used in a brief drug-free novelty
task were handled for 3 min per day for 3 days before the start of the present experiment. Rats
were injected with 10 mg/kg caffeine or saline 15 min before chamber placement. During each
20-min session, there were 8 presentations of the 15-s light CS. On caffeine sessions, each
offset of the stimulus lights was followed immediately by 4-s access to sucrose. To decrease
predictability of the light stimuli within and between sessions, four different computer
programs controlling lights and sucrose deliveries were used. The average time to the first light
onset was 135 s (range of 90–180 s) and the average intertrial interval was 120 s (range of 75–
165 s). For saline sessions, light presentations were matched with those of caffeine sessions
and 4-s ‘empty’ intervals occurred in place of sucrose to insure identical session length.
Caffeine and saline sessions were intermixed randomly with the restriction that no more than
two of a session type (caffeine or saline) occurred in a row and that all four programs for each
session type were used across eight session blocks. Training continued for 22 caffeine and 22
saline sessions.
2.4.2. Generalization Testing—Following acquisition of the discrimination, rats were
tested for generalization to varying doses of caffeine (0.625, 1.25, 2.5, 5, 10, 20, and 30 mg/
kg), nicotine (0.025, 0.05, 0.1, and 0.2 mg/kg), and amphetamine (0.125, 0.25, 0.5, and 1 mg/
kg). On the first 4 consecutive days of a 5-day cycle, rats received two caffeine and two saline
training sessions intermixed as described for acquisition training. If a rat met the discrimination
criteria (see later), a 4-min test session was conducted on day 5 of the cycle. During each test,
there was a single presentation of the light CS. Four different test programs, presented in
random order, matched the timing of the first light presentation to the four training programs.
If discrimination criteria for testing were not met, the rat remained in its home cage on day 5
and resumed training on the following day. Importantly, these 5-day cycles continued until
each rat completed testing with all ligands and doses unless otherwise noted.
Testing of caffeine and nicotine was intermixed. Each dose was tested in two different random
orders. Nicotine doses above 0.2 mg/kg were not tested because acute injections of these higher
doses consistently produce locomotor ataxia (e.g., Bevins et al., 2001). Upon completion of
the caffeine and nicotine generalization tests, rats were tested with two different random orders
of amphetamine. On six occasions, additional tests were conducted due to discrepant findings
on the initial two tests with the same dose/compound. For each rat, dipper entries were averaged
over repeated tests and these averages were used for analyses and figures. Additionally, two
saline test sessions were intermixed within the testing orders to provide a baseline for
comparison. One saline injection was IP 15 min before placement in the chamber (cf. caffeine
and amphetamine injections); the other saline injection was SC 5 min before placement (cf.
nicotine injections). The order of these injection types was random for each rat. Given the lack
of statistical difference between these saline tests, t(5)=1.41, P=0.217, the mean for the two
test sessions was used for analyses and figures.
2.4.3. Dependent Measures and Criteria—The primary dependent measure for
acquisition and test sessions was an elevation score: the number of dipper entries recorded
during the 15-s presentation of the light CS minus the number of dipper entries recorded during
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the 15-s interval before the light (CS period – pre-CS period). A positive value indicates more
dipper entries during the CS. Additionally, a rate measure was calculated by subtracting the
number of dipper entries per second during the CS from the number of dipper entries per second
during the pre-CS period (cf. Experiment 2a and 2b). Before each generalization test was
conducted, rats were required to meet performance criteria based on the elevation scores
calculated for the first 4 drug and saline sessions of each 5-day cycle. On average, elevation
scores on drug sessions had to be at least three responses greater than elevation scores on
respective saline session (1st drug session vs. 1st and 2nd saline session, etc.). Additionally, on
the last caffeine session, the elevation score for the first light presentation had to be at least
one higher than the last saline session (cf. Bevins et al., 2006;Palmatier et al., 2004,2005).
General activity was defined as number of chamber beam breaks in the 4-min test sessions.
2.5. Experiment 2a: 10 mg/kg Caffeine as a CS
2.5.1. Preliminary Training—Rats (n=6) were previously used in either a brief place
conditioning or locomotor conditioning study before the start of the present experiment. Rats
were handled for at least 3 min per day for 3 days before dipper training commenced. Dipper
training consisted of three 50-min sessions. Each daily session was initiated with the rat’s first
head entry into the dipper. The probability of receiving sucrose decreased from 0.167 to 0.05
per 60 s over the three sessions (approximately 2.5 to 0.75 sucrose deliveries per min).
2.5.2. Acquisition—Acquisition began the day after the last dipper training session and was
virtually identical to the positive feature procedures of Experiment 1 except the light cues were
not presented in any session. During caffeine sessions, the time varied between sucrose
deliveries (mean = 141 s; range 90–210 s) and the first sucrose presentation (mean = 120 s;
range 90–150 s). On saline sessions, no sucrose was delivered, but programs were matched to
the timing of caffeine programs with a 4-s ‘empty’ interval where sucrose would have been
delivered to equate the dipper entry data for later analysis. Training continued for 28 caffeine
and 28 saline sessions. Conditioned responding evoked by the caffeine CS was weak and did
not lend itself to generalization and substitution testing (see Results). Thus, training was longer
than the positive feature experiment in an attempt to enhance conditioned response strength.
2.5.4. Dependent Measure—An elevation score cannot be calculated in Experiment 2a (or
Experiment 2b; see later) given that the CS is the interoceptive effects of caffeine and not brief
illumination of cue lights. Accordingly, the primary dependent measure for acquisition was
the rate of dipper entries per s before the first sucrose delivery or an equivalent time on saline
sessions. Using only dipper entries before the first sucrose delivery avoids any influence of the
US in the measure of conditioning. Further, a rate measure was used because time to the first
sucrose delivery varied across sessions (cf. Besheer et al., 2004;Murray and Bevins, in
press;Wilkinson et al., 2006).
2.6. Experiment 2b: 30 mg/kg Caffeine as a CS
Rats (n=7) that served previously in a brief place conditioning or locomotor conditioning
procedure were used in this experiment. Handling, dipper training, acquisition, and the
dependent measure were identical to Experiment 2a except that 30 mg/kg caffeine was used
as the CS.
2.7. Data Analyses
Two-way ANOVAs were conducted on elevation scores (Experiment 1) and dipper entry rates
(Experiments 2a and 2b) across caffeine versus saline sessions. Significant interactions
prompted Fisher’s least significant difference (LSD) tests that control for Type I error rate. For
generalization and substitution testing, one-way ANOVAs determined if there were effects of
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test doses. General chamber activity was analyzed in a similar fashion. A significant F-value
prompted Fisher’s LSD tests to compare test doses of drug to a saline baseline, as well as the
training dose of caffeine. A median effective dose (ED50) was calculated using the ascending
limb of the caffeine generalization curve. Statistical significance was declared using a two-
tailed rejection region of 0.05 for all tests.
3. Results
3.1. Experiment 1: Caffeine as a Positive Feature
3.1.1. Acquisition—Figure 1A shows the average elevation score of the eight light CS
presentations per session across acquisition training. A two-way repeated measures ANOVA
revealed a main effect of Drug (caffeine versus saline), F(1,5)=64.93, P<0.001, a main effect
of Session, F(21,105)=9.20, P<0.001, and a significant Drug x Session interaction, F(21,105)
=8.34, P<0.001, Mean square error (MSE)=1.29. Elevation scores on caffeine sessions were
higher than recorded on saline sessions 12 to 22, LSDminimum mean difference (mmd)=1.31. Figure
1B shows the elevation score for the first light presentation of each session across acquisition.
For the elevation score measure, there was a main effect of Drug, F(1,5)=11.03, P=0.021, a
main effect of Session, F(21,105)=2.31, P=0.003, and a significant Drug x Session interaction,
F(21,105)=2.36, P=0.002, MSE=4.75. The first elevation scores on caffeine sessions were
higher than on saline sessions 17 to 22, LSDmmd=2.52. For comparison with the CS data of
Experiments 2a and 2b, the right y-axis shows the elevation score based on the rate of dipper
entries. Obviously, the results of the ANOVA were identical since this measure merely divides
all pre-CS and CS values by 15 s; the LSDmmd was 0.167 (MSE=0.021).
3.1.2. Generalization and Substitution Testing—For the generalization function for
caffeine as a positive feature (see Figure 2A) there was a significant effect of Dose, F(7,35)
=4.78, P=0.001, MSE=6.19. Elevation scores were higher on 5 to 30 mg/kg caffeine than on
saline, LSD mmd=2.93. Additionally, elevation scores were lower than the caffeine training
dose (10 mg/kg) at 0 to 2.5 mg/kg caffeine. The ED50 for the linear portion of the caffeine
generalization curve was 4.16 mg/kg. Figure 2B shows general chamber activity during the
caffeine generalization tests. The one-way ANOVA revealed that activity differed across
caffeine dose, F(7,35)=2.95, P=0.015, MSE=426.22. Activity was higher on 1.25 to 20 mg/kg
caffeine than saline, LSD mmd=24.34. Conversely, relative to the caffeine training dose, activity
was significantly lower for 0.625 and 30 mg/kg and saline.
Nicotine did not substitute for the caffeine positive feature, F(4,20)=2.34, P=0.09 (Figure 3A).
Further, nicotine did not significantly alter general chamber activity during nicotine
substitution testing, F(4,20)=2.40, P=0.084 (Figure 3B). Figure 3C shows the amphetamine
substitution results. One rat consistently failed to meet discrimination criteria in this test phase
and was removed during this portion of the study. Amphetamine did not substitute for the
caffeine positive feature, F(4,16)=2.34, P=0.099. However, amphetamine did alter general
chamber activity, F(4,16)=4.47, P=0.013, MSE=502.32 (Figure 3D). Activity was higher on
0.25 to 1 mg/kg amphetamine than saline, LSD mmd=30.05. For comparison, an activity
baseline for caffeine was generated from the chamber beam breaks in the first 4 min of the last
caffeine training session before testing 0.5 mg/kg amphetamine. Because each rat was tested
twice on amphetamine, this value was randomly taken from the first or second test session for
a given rat (Mean Activity=104±4 beam breaks; see solid line with juxtaposed dashed lines in
Figure 3D). Amphetamine-induced activity was not significantly different from this caffeine
baseline.
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3.2. Experiment 2a: 10 mg/kg Caffeine as a CS
For acquisition training with the 10 mg/kg caffeine CS, there was a main effect of Session, F
(27, 135)=9.74, P<0.001, and a significant Drug x Session interaction, F(27,135)=1.78,
P=0.017, MSE=0.001; the main effect of Drug, F(1,5)=4.67, P=0.08, was not significant (see
Figure 4A). Follow-up analyses indicated that dipper entry rates were lower on caffeine than
saline for session 2, and higher on caffeine than saline for sessions 8, 11–12, 16–18, and 21–
28, LSDmmd=0.04. These results indicate that, albeit weak, caffeine acquired control of goal
tracking.
3.3. Experiment 2b: 30 mg/kg Caffeine as a CS
For acquisition training with the 30 mg/kg caffeine CS, there was a main effect of Drug, F
(1,6)=11.27, P=0.015, a main effect of Session, F(27,162)=11.50, P<0.001, and a significant
Drug x Session interaction, F(27,162)=1.61, P<0.036, MSE=0.002 (see Figure 4B).
Conditioned responding was lower on caffeine than saline for session 8, but higher on sessions
20–23 and 26–27, LSDmmd=0.05. This pattern of results also indicates weak and transient
control of a goal-tracking CR by a higher dose of caffeine.
4. General Discussion
Caffeine readily functioned as a positive feature (occasion setter) in this appetitive Pavlovian
drug conditioning task. That is, anticipatory head entries into the dipper increased during the
light CS only on caffeine sessions; no such increase during the same light was seen on saline
sessions. This finding extends past research by adding caffeine to the list of drugs that function
as a positive feature including amphetamine, nicotine, cocaine, midazolam, morphine,
methadone, pentobarbital, and chlordiazepoxide (Jaeger and Mucha, 1990;Maes and Vossen,
1997;Palmatier et al., 2005;Parker et al., 1994;Revusky et al., 1982;Troisi and Akins, 2004).
Notably, when we used an average of the 8 trials within each training session as the dependent
measure (see Figure 1A), conditioned responding emerged after 24 sessions (12 caffeine and
12 saline sessions intermixed). This measure may, however, over estimate acquisition speed
of the drug discrimination. That is, sucrose delivery after the initial light presentation, rather
than caffeine, might function as a signal for later deliveries of sucrose on caffeine sessions.
Using only the first light presentation as the measure of conditioned responding avoids this
difficulty. With this measure, conditioned responding to the light CS, which must be
‘modulated’ by the interoceptive effects of caffeine, required 34 sessions to emerge (17 of each
session type). In the present research, the acquisition rate using 10 mg/kg caffeine as the drug
feature was similar to the two-lever operant drug discrimination paradigm with food reinforcer
using higher caffeine doses. For example, Mariathasan and Stolerman (1992) found that rats
took an average of 40 sessions to discriminate 20 mg/kg caffeine from saline. Modrow et al.
(1980) reported acquisition within approximately 50 sessions if 32 mg/kg caffeine was the
training dose. When comparable caffeine doses were used in a discrete shock avoidance task,
10 mg/kg caffeine took between 51 and 108 sessions to acquire control of responding
(Holtzman, 1986,1987;Mumford and Holtzman, 1991;Powell et al., 1999).
Conditional control of responding to the light CS was sensitive to the dose of caffeine during
testing. Rats trained with caffeine as a positive feature showed a decrease in conditioned
responding to the light as the test dose decreased below the 10 mg/kg training dose; increasing
the dose up to 30 mg/kg had little effect on the CR (see Holtzman, 1986;Mumford and
Holtzman, 1991;Powell et al., 1999 for a similar pattern with a caffeine discriminative
stimulus). The ED50 for the caffeine feature was 4.16 mg/kg. This value is similar to that in
the operant drug discrimination literature (Holtzman 1986, training dose=10 mg/kg,
ED50=3.17 mg/kg).
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Nicotine did not substitute for caffeine in the present study suggesting that nicotinic
acetylcholine receptors do not play a role in the interoceptive stimulus effects of 10 mg/kg
caffeine. This is somewhat in contrast to the findings of Palmatier et al. (2005) in which caffeine
substituted for a nicotine positive feature. First, the interoceptive caffeine stimulus might differ
when high versus low doses of the drug are administered (e.g., Mumford and Holtzman,
1991). For example, when caffeine substituted for 0.4 mg base/kg nicotine (Palmatier et al.,
2005) the ED50 was higher than the 10 mg/kg training dose used in Experiment 1 (i.e.,
ED50=15.45 mg/kg). Thus, higher doses of caffeine and nicotine may share similar stimulus
properties, whereas lower doses are more dissociable. Unfortunately, nicotine doses above 0.2
mg/kg in the present research would have likely produced severe locomotor impairment when
given acutely, precluding any meaningful test of these high doses. A second reason that these
findings contrast with those of Palmatier et al. (2005) is that substitution between the stimulus
effects of nicotine and caffeine may be asymmetrical. The failure of Modrow et al. (1981) to
find substitution of nicotine (0.1 to 0.4 mg/kg) for a relatively high dose (32 mg/kg) caffeine
discriminative stimulus supports this asymmetry account. Further studies are needed to help
decide between these possible explanations.
Amphetamine did not substitute for the caffeine feature in Experiment 1. Although the mean
level of dipper entries during the light CS increased at the 0.25 mg/kg amphetamine dose, this
trend did not continue at higher doses and there was not a significant F-value on this substitution
data. Accordingly, the result suggests that this low dose of caffeine does not differentially
modulate conditioned responding to a light CS via increased synaptic dopamine. Interestingly,
in the operant drug discrimination literature, amphetamine partially to fully substitutes for the
discriminative stimulus effects of caffeine. For example, in the discrete shock avoidance
paradigm, 1 mg/kg amphetamine fully substituted for a 10 mg/kg caffeine discriminative
stimulus (Mumford and Holtzman, 1991). In the appetitive paradigm, the 1 mg/kg dose of
amphetamine fully substituted for a 20 mg/kg caffeine discriminative stimulus (Mariathasan
and Stolerman, 1992); 2 mg/kg amphetamine partially substituted for a 32 mg/kg caffeine
discriminative stimulus (Modrow et al., 1981). This difference between the caffeine as a
positive drug feature in a Pavlovian goal-tracking task and the schedule-controlled two-lever
operant discrimination task highlights the possibility that the neuropharmacological processes
underlying the signaling effects of caffeine may differ depending on its behavioral function
(see Palmatier et al., 2005 for a similar suggestion). As such, it will be important to explore
the potential similarities and differences. One especially interesting avenue for this research
will be in the transfer of a discriminative stimulus for a positive feature and vice versa (cf.
Davidson et al., 1988). Will transfer occur and does a drug’s training history as a discriminative
stimulus or positive feature affect the substitution and antagonism pattern of other ligands?
The lack of nicotine or amphetamine substitution for the caffeine feature indicates that
discrimination performance was maintained by more than the presence or absence of a drug.
That is, there was pharmacological specificity to the interoceptive stimulus effects of the
caffeine in the present positive drug feature task. Further, the lack of amphetamine substitution,
a classic locomotor stimulant (e.g., Geyer et al., 1986), suggests that the discrimination was
based on more than whether the drug has or does not have stimulant effects. In fact,
amphetamine (0.25 to 1 mg/kg) significantly increased chamber activity above that of saline,
yet that activity was comparable to caffeine (cf. Figure 3D). However, this enhanced
locomotion did not translate into increased dipper entries during the light CS on substitution
tests. This pattern of results clearly eliminates a psychomotor stimulant account of caffeine’s
modulatory control over goal-tracking and further supports the potential utility of the Pavlovian
drug discrimination task for studying the interoceptive stimulus effects of drugs.
In Experiment 2a, caffeine at 10 mg/kg functioned, at best, as a weak interoceptive contextual
CS. As a contextual CS, caffeine signaled that sucrose would be available intermittently
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throughout the session. This weak control of a goal-tracking CR is in contrast to the ability of
caffeine at 10 mg/kg to function as a Pavlovian drug feature (Experiment 1) and as an operant
discriminative stimulus (e.g., Mumford and Holtzman, 1991). This difference is remarkable
given the similarity of the procedures used in each of the current experiments. At least three
possible accounts of this difference can be addressed by the present research. One possibility
is that the salience of the caffeine was not sufficient for it to function as a contextual CS. This
account is made less tenable by the fact that caffeine at 10 mg/kg readily served as a contextual
occasion setter (Experiment 1). However, as an occasion setter, weak stimulus salience might
be aided by the presentation of a brief light CS. Additionally, when the caffeine dose was
increased to 30 mg/kg (Experiment 2b) the drug stimulus did not control robust goal tracking.
In fact, goal tracking at this higher dose appeared to be worse.
A second alternative account would suggest that the rats fail to learn the discrimination because
without a discrete CS to signal sucrose, the rats fail to obtain the sucrose in these caffeine CS
sessions (cf. drug feature protocol). We are confident that the rats received most of the sucrose
because we had written into the computer programs code that counted dipper entries during
each 4-s sucrose delivery. During the last five caffeine sessions, the 10 mg/kg group
(Experiment 2a) had dipper entries during 79% of deliveries; the 30 mg/kg group (Experiment
2b) had dipper entries during 84% of deliveries.
Finally, the difference in preliminary training between the two tasks may account for the current
findings. That is, rats in the CS experiments (Experiments 2a and 2b) were trained to access
sucrose before beginning acquisition; rats in the drug feature experiment (Experiment 1) were
not. Our enthusiasm for this explanation is severely diminished by recently published research
from our laboratory (Palmatier and Bevins, 2007). In that research, all rats were given
preliminary dipper training as described for the present caffeine CS experiments using
amphetamine or chlordiazepoxide as the interoceptive Pavlovian stimulus. Similar to the
findings in the current research, the amphetamine and chlordiazepoxide readily functioned as
positive drug features, yet the same drugs in the CS task did not (Palmatier and Bevins,
2007). Further, nicotine readily functions as a CS in rats that have received preliminary dipper
training (Besheer et al., 2004) indicating that dipper training before excitatory conditioning of
a drug state CS does not prevent acquisition of a CR. Combined, these findings suggest that
we look elsewhere for a possible explanation for the differences in caffeine as a CS versus drug
feature.
Although nicotine readily functions as a CS and evokes a robust and stable CR under the current
training protocol (Besheer et al., 2004), the poor control of conditioned responding by the
caffeine CS is not completely surprising. We have found that amphetamine and
chlordiazepoxide do not directly evoke a goal-tracking CR even though both drugs readily
serve as drug features that facilitate responding to a discrete stimulus (Palmatier et al.,
2005;Palmatier and Bevins, 2007). Combined, these findings pose an interesting puzzle
regarding why chlordiazepoxide and amphetamine do not readily function as an interoceptive
CS and caffeine evokes only a weak conditioned response, yet these same drugs serve as drug
features that modulate the same goal-tracking CR to a discrete stimulus. The only substantive
procedural difference between the CS and positive feature protocol is the presence of the
discrete stimulus occurring immediately before each sucrose delivery. Drug dose, injection-
to-placement interval, number of trials per session, etc. are identical. Two, nicotine evokes/
modulates a goal-tracking response whether trained as a CS or as a positive drug feature. As
noted by Palmatier and Bevins (2007), an account based on drug effects overshadowing the
rewarding effects of sucrose predicts that none of the drugs would serve as a feature. That is,
if processing of the drug CS is effectively competing with and minimizing processing of the
US, then the drugs should also not function as positive features. A similar criticism applies to
a response interference account.
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This discussion tempts us to conclude that there is something distinct about nicotine that allows
it to acquire direct control of a goal-tracking CR. Indeed, there is a body of literature
demonstrating that nicotine enhances the incentive salience/unconditioned reinforcing effects
of stimuli. For example, nicotine exposure in rats increases Pavlovian discriminative approach
behavior for water (Olausson et al., 2003;2004), as well as operant responding for a mildly
reinforcing visual stimulus (Donny et al., 2003). Perhaps such a mechanism can help us explain
why nicotine appears to function better as a CS in this Pavlovian appetitive conditioning task
than the others drugs tested to date (i.e., amphetamine, caffeine, and chlordiazepoxide).
Presently, we assume that a drug state CS should acquire additional appetitive properties by
virtue of its pairings with sucrose—apparently these pairing are insufficient except for nicotine
to evoke a robust CR. The incentive-enhancing effect of nicotine might increase the appetitive
effects of sucrose. If so, such an increase is functionally equivalent to using a better quality
US when nicotine serves as the interoceptive Pavlovian stimulus [see Bevins and Palmatier
(2004) for a more detailed discussion of this potential interaction]. A general result in Pavlovian
conditioning research is that conditioned excitation (CR magnitude) increases with US quality
(e.g., Bevins et al., 1997;Pavlov, 1927).
This enhanced incentive salience account makes several predictions that deserve attention. One
prediction is that conditioned responding evoked by the discrete CS in positive feature
experiments should be higher when nicotine serves as the feature. Our research has not
supported this prediction. For example, there was little difference in the expression of
conditioned responding when rats were trained with nicotine, chlordiazepoxide, or
amphetamine as positive drug features (Palmatier et al., 2005). However, this counter evidence
should be taken with some caution. That is, the measure of conditioning is an increase in
responding during a 15-s CS. Perhaps dipper entries are at a maximum when a 15 s CS is
employed. Such a ceiling effect would obscure our ability to see an increase in CR magnitude
with drug state. Also, this account suggests that a more appetitive conditioning situation could
work with the other drug states as CSs. Indeed, the 10 mg/kg caffeine CS did evoke a weak
CR. Perhaps increasing the number of sucrose deliveries per session would increase the CR
magnitude in a manner similar to that shown with a nicotine CS (Wilkinson et al., 2006). Albeit
possible, this strategy did not work for amphetamine. As noted earlier, amphetamine did not
function as a CS using the 8 sucrose deliveries of present research (Palmatier and Bevins,
2007). A recent unpublished experiment in our laboratory has shown that even 36 sucrose
deliveries in 20-min sessions was not sufficient for amphetamine to serve as a CS. Finally, our
enthusiasm for the nicotine incentive enhancement account is further diminished by the finding
that amphetamine also enhances the incentive effects of stimuli (e.g., Simon and Setlow,
2006).
In sum, the present research extends the stimulus effects of caffeine to the role of facilitating
conditioned responding to an appetitive CS-US association. As a positive feature, caffeine’s
modulatory control was pharmacologically specific; neither amphetamine nor nicotine
substituted for the caffeine feature. In contrast, caffeine’s ability to directly evoke a conditioned
response (i.e., function as a CS) was sufficiently weak that it did not allow for subsequent
generalization testing. Future research will need to parse apart controlling variables relevant
for the interoceptive effects of a drug to serve as a positive feature (occasion setter) versus a
conditional stimulus. Given that a nicotine CS readily evokes robust conditioning responding
unlike chlordiazepoxide, amphetamine, or caffeine, part of this process might include
identifying what makes the interoceptive effects of nicotine distinct in this protocol.
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Figure 1.
Panel A shows the mean elevation scores (±1 SEM) for acquisition of the caffeine positive
feature in Experiment 1. Panel B shows acquisition using the first elevation scores. The left
axis shows elevation scores, and the right axis shows the same elevation score based on dipper
entries per s (±1 SEM). For both panels, * indicates a significant difference between the
corresponding caffeine and saline session, P<0.05.
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Figure 2.
Panel A shows the mean elevation scores (±1 SEM) on caffeine generalization tests of
Experiment 1. Panel B shows the mean general activity (±1 SEM). For both panels, * indicates
a significant difference from saline. # represents a significant difference from the caffeine
training dose (10 mg/kg), P<0.05.
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Figure 3.
Panel A shows the mean elevation scores (±1 SEM) of nicotine substitution in Experiment 1.
Panel B shows the mean general activity (±1 SEM) of nicotine substitution. Panel C shows the
mean elevation scores (±1 SEM) of amphetamine substitution. Panel D shows the mean general
activity (±1 SEM) of amphetamine substitution. * indicates a significant difference from saline.
The solid line indicates the baseline activity of the caffeine training dose (dotted lines ±1 SEM),
P<0.05.
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Figure 4.
Panel A shows the dipper entry rates (±1 SEM) for acquisition of the 10 mg/kg caffeine CS
(Experiment 2a). Panel B shows the dipper entry rates (±1 SEM) for acquisition of the 30 mg/
kg caffeine CS (Experiment 2b). For a rat in this experiment, 2 caffeine sessions were given
that should have been saline sessions. These 2 caffeine sessions were not included in analysis,
but to prevent loss of all data in the repeated measures ANOVA, saline values were generated
by averaging the saline responding of the sessions before and after the missed saline sessions.
For both panels, * indicates a significant difference between corresponding caffeine and saline
session, P<0.05.
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